Literature DB >> 15288631

Cytokines, their genetic polymorphisms, and outcome after abdominal aortic aneurysm repair.

M J Bown1, T Horsburgh, M L Nicholson, P R F Bell, R D Sayers.   

Abstract

BACKGROUND: Excessive cytokine production has been implicated in the development of organ failure. Polymorphic sites in cytokine genes have been shown to affect levels of production in vitro and may influence cytokine production in vivo. The aims of this study were to determine if cytokines or their genetic polymorphisms were related to outcome after abdominal aortic aneurysm (AAA) repair.
METHODS: A prospective study of 135 patients undergoing open AAA repair. Plasma levels of TNF-alpha, IL-1beta, IL-6 and IL-10 were measured 24 h post-operatively and genotypes for the TNF-alpha -308, IL-1beta+3953, IL-6 -174, IL-10 -1082 and IL-10 -592 polymorphisms were determined for each patient.
RESULTS: After elective AAA high levels of IL-10 were associated with both prolonged critical care (P<0.001) and hospital stay (P=0.001). The presence of a G allele at the IL-6 -174 locus was associated with a higher incidence of organ failure (P=0.04) and an A allele at TNF-alpha -308 with prolonged critical care stay (P=0.03). After ruptured AAA the development of multi-organ failure was associated with high levels of IL-6 (P=0.01) and TNF-alpha (P=0.04). High TNF-alpha levels were also associated with mortality (P=0.01).
CONCLUSION: Post-operative cytokine levels are related to outcome after AAA repair. Cytokine gene polymorphisms may provide a method for determining which patients are at high risk of complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288631     DOI: 10.1016/j.ejvs.2004.05.008

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  7 in total

Review 1.  [The importance of cytokines in the posttraumatic inflammatory reaction].

Authors:  F Hildebrand; H-C Pape; C Krettek
Journal:  Unfallchirurg       Date:  2005-10       Impact factor: 1.000

Review 2.  Interleukin-6 in surgery, trauma, and critical care part II: clinical implications.

Authors:  Randeep S Jawa; Sergio Anillo; Kristin Huntoon; Heinz Baumann; Mahmoud Kulaylat
Journal:  J Intensive Care Med       Date:  2011 Mar-Apr       Impact factor: 3.510

Review 3.  Concept of the aortic aneurysm repair-related surgical stress: a review of the literature.

Authors:  Demetrios N Moris; Michalis I Kontos; Eleftherios I Mantonakis; Antonios K Athanasiou; Eleftherios D Spartalis; Chris N Bakoyiannis; George P Chrousos; Sotirios E Georgopoulos
Journal:  Int J Clin Exp Med       Date:  2014-09-15

4.  Real-time, personalized medicine through wearable sensors and dynamic predictive modeling: a new paradigm for clinical medicine.

Authors:  Jonathan Tyler; Sung Won Choi; Muneesh Tewari
Journal:  Curr Opin Syst Biol       Date:  2020-07-07

Review 5.  Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review.

Authors:  Diamantis I Tsilimigras; Fragiska Sigala; Georgios Karaolanis; Ioannis Ntanasis-Stathopoulos; Eleftherios Spartalis; Michael Spartalis; Nikolaos Patelis; Alexandros Papalampros; Chandler Long; Demetrios Moris
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

6.  HLA-DR expression on monocytes and systemic inflammation in patients with ruptured abdominal aortic aneurysms.

Authors:  Jan Willem W Haveman; Aad P van den Berg; Eric L G Verhoeven; Maarten W N Nijsten; Jan J A M van den Dungen; Hauw T The; Jan H Zwaveling
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

7.  Role of TGF-β pathway polymorphisms in sporadic thoracic aortic aneurysm: rs900 TGF-β2 is a marker of differential gender susceptibility.

Authors:  Letizia Scola; Federica M Di Maggio; Loredana Vaccarino; Manuela Bova; Giusy I Forte; Calogera Pisano; Giuseppina Candore; Giuseppina Colonna-Romano; Domenico Lio; Giovanni Ruvolo; Carmela R Balistreri
Journal:  Mediators Inflamm       Date:  2014-02-24       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.